IceCure Medical (ICCM) Long-Term Deferred Tax (2020 - 2022)

IceCure Medical (ICCM) has reported Long-Term Deferred Tax for 3 consecutive years, with $17.3 million the latest figure, recorded in Q4 2022.

• On a quarterly basis, Long-Term Deferred Tax rose 21.84% year-over-year to $17.3 million in Q4 2022; TTM through Dec 2022 was $17.3 million, a 21.84% increase from a year earlier, with the FY2022 full-year figure at $17.3 million, up 21.84% from the prior year.
• Long-Term Deferred Tax was $17.3 million for Q4 2022 at IceCure Medical, up from $14.2 million in the prior quarter.
• Over five years, Long-Term Deferred Tax peaked at $17.3 million in Q4 2022 and troughed at $12.0 million in Q4 2020.
• A 3-year average of $14.5 million and a median of $14.2 million in 2021 frame the typical range for Long-Term Deferred Tax.
• Across the five-year window, Long-Term Deferred Tax gained 17.94% in 2021 and increased 21.84% in 2022, its largest moves.
• Over 3 years, Long-Term Deferred Tax stood at $12.0 million in 2020, then rose by 17.94% to $14.2 million in 2021, then climbed by 21.84% to $17.3 million in 2022.
• The last three Long-Term Deferred Tax figures came in at $17.3 million (Q4 2022), $14.2 million (Q4 2021), and $12.0 million (Q4 2020), per Business Quant data.